These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 28006994)
1. The role of human epididymis secretory protein E4 in patients with endometrial cancer and premalignant endometrial lesions. Yılmaz SA; Altınkaya SÖ; Kerimoglu ÖS; Tazegül Pekin A; Akyürek F; Ilhan TT; Benzer N; Unlu A; Yuksel H; Celik C J Obstet Gynaecol; 2017 Jan; 37(1):58-63. PubMed ID: 28006994 [TBL] [Abstract][Full Text] [Related]
2. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma]. Zhang AM; Zhang P Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745 [TBL] [Abstract][Full Text] [Related]
3. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET). Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654 [TBL] [Abstract][Full Text] [Related]
4. Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study. Fanfani F; Restaino S; Cicogna S; Petrillo M; Montico M; Perrone E; Radillo O; De Leo R; Ceccarello M; Scambia G; Ricci G Int J Gynecol Cancer; 2017 Jul; 27(6):1200-1205. PubMed ID: 28557834 [TBL] [Abstract][Full Text] [Related]
5. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer. Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma. Saarelainen SK; Peltonen N; Lehtimäki T; Perheentupa A; Vuento MH; Mäenpää JU Am J Obstet Gynecol; 2013 Aug; 209(2):142.e1-6. PubMed ID: 23583212 [TBL] [Abstract][Full Text] [Related]
7. Risk and predictors of malignancy in women with endometrial polyps. Wethington SL; Herzog TJ; Burke WM; Sun X; Lerner JP; Lewin SN; Wright JD Ann Surg Oncol; 2011 Dec; 18(13):3819-23. PubMed ID: 21701931 [TBL] [Abstract][Full Text] [Related]
8. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study. Angioli R; Plotti F; Capriglione S; Montera R; Damiani P; Ricciardi R; Aloisi A; Luvero D; Cafà EV; Dugo N; Angelucci M; Benedetti-Panici P Tumour Biol; 2013 Feb; 34(1):571-6. PubMed ID: 23179397 [TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment of precancer and cancer of endometrium]. Ivanov S; Khadzhiolov N; Batashki I Akush Ginekol (Sofiia); 2007; 46(6):12-4. PubMed ID: 17974165 [TBL] [Abstract][Full Text] [Related]
10. Serum HE4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study. Barr CE; Sergeant JC; Agnew HJ; Bolton J; McVey RJ; Crosbie EJ BJOG; 2023 Jul; 130(8):941-948. PubMed ID: 36715558 [TBL] [Abstract][Full Text] [Related]
11. [The importance of HE4 in differential diagnosis of endometrial cancer]. Minář L; Klabenešová I; Jandáková E Ceska Gynekol; 2015 Aug; 80(4):256-63. PubMed ID: 26265413 [TBL] [Abstract][Full Text] [Related]
12. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334 [TBL] [Abstract][Full Text] [Related]
13. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia. Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295 [TBL] [Abstract][Full Text] [Related]
14. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management. Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483 [TBL] [Abstract][Full Text] [Related]
15. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer. Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338 [TBL] [Abstract][Full Text] [Related]
16. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge. Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging. Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178 [TBL] [Abstract][Full Text] [Related]
18. Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management. Presl J; Ovesna P; Novotny Z; Vlasak P; Bouda J; Kostun J; Topolcan O; Kucera R; Bednarikova M; Weinberger V Anticancer Res; 2017 May; 37(5):2697-2702. PubMed ID: 28476847 [TBL] [Abstract][Full Text] [Related]
19. Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer. Espiau Romera A; Coronado Martín PJ; Chóliz Ezquerro M; Cuesta Guardiola T; Adiego Calvo I; Baquedano Mainar L Int J Gynaecol Obstet; 2021 Apr; 153(1):64-70. PubMed ID: 33156532 [TBL] [Abstract][Full Text] [Related]
20. Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer. Wang Y; Han C; Teng F; Bai Z; Tian W; Xue F Int J Gynaecol Obstet; 2017 Jan; 136(1):58-63. PubMed ID: 28099710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]